Table 1.
Patient baseline characteristics
| Parameter | Value |
|---|---|
| Male sex (%)a | 70 (55.6) |
| Age, yearsb | 59 (16) |
| Diabetes duration, yearsb | 11.5 (9) |
| HbA1c (%)c | 8.4±1.6 |
| BMI (kg/m2)c | 31.7±5.1 |
| Neuropathy (%)a | 87 (69) |
| Chronic kidney disease (%)a | 37 (29.4) |
| Uncontrolled hypertension (%)a | 42 (33.3) |
| Dyslipidemia (%)a | 83 (65.9) |
| Generalized anxiety disorder (%) | 25 (19.8) |
| Depression disorder (%) | 11 (8.7) |
| Treatment with metformin (%) | 71 (56.3) |
| Treatment with sulfonylurea (%) | 9 (7.1) |
| Treatment with DPP4i (%) | 19 (15.1) |
| Treatment with GLP1 RA (%) | 3 (2.4) |
| Treatment with basal insulin (%) | 82 (65.1) |
| Treatment with rapid-acting insulin (%) | 73 (57.9) |
Notes:
a
Dichotomous variables. Results presented as n (%).
b
Numeric variables without Gaussian distribution. Results presented as median and interquartile range.
c
Numeric variables with Gaussian distribution. Results presented as mean ± standard deviation.
Abbreviations: BMI, body mass index; DPP4i, DPP4i inhibitor; RA, receptor agonist.